Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy
暂无分享,去创建一个
E. Diamandis | K. Saijoh | C. Kuk | K. Takehara | F. Shirasaki | N. Komatsu | E. Diamandis | Cynthia Kuk | Kazuhiko Takehara | Nahoko Komatsu
[1] T. Kishi,et al. Proteolytic processing of human growth hormone by multiple tissue kallikreins and regulation by the serine protease inhibitor Kazal-Type5 (SPINK5) protein. , 2007, Clinica chimica acta; international journal of clinical chemistry.
[2] E. Diamandis,et al. A Potential Role for Multiple Tissue Kallikrein Serine Proteases in Epidermal Desquamation* , 2006, Journal of Biological Chemistry.
[3] L. Chao,et al. The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction , 2006, Biological chemistry.
[4] E. Diamandis,et al. Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs) , 2006, Biological chemistry.
[5] E. Diamandis,et al. Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and more , 2006, Biological chemistry.
[6] E. Diamandis,et al. Quantification of eight tissue kallikreins in the stratum corneum and sweat. , 2006, The Journal of investigative dermatology.
[7] M. Walden,et al. hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6 , 2005, The British journal of dermatology.
[8] E. Diamandis,et al. Quantification of human tissue kallikreins in the stratum corneum: dependence on age and gender. , 2005, The Journal of investigative dermatology.
[9] Y. Hanakawa,et al. Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI) , 2005, Biological chemistry.
[10] A. Bowcock,et al. Getting under the skin: the immunogenetics of psoriasis , 2005, Nature Reviews Immunology.
[11] E. Diamandis,et al. Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases , 2005, The British journal of dermatology.
[12] E. Diamandis,et al. Biochemical and Enzymatic Characterization of Human Kallikrein 5 (hK5), a Novel Serine Protease Potentially Involved in Cancer Progression* , 2005, Journal of Biological Chemistry.
[13] T. Kishi,et al. Enzymatic profiling of human kallikrein 14 using phage-display substrate technology , 2005, Biological chemistry.
[14] A. Ishida-Yamamoto,et al. LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum. , 2005, The Journal of investigative dermatology.
[15] F. Marceau,et al. The kallikrein-kinin system: current and future pharmacological targets. , 2005, Journal of pharmacological sciences.
[16] M. Brattsand,et al. A proteolytic cascade of kallikreins in the stratum corneum. , 2005, The Journal of investigative dermatology.
[17] A. Sonnenberg,et al. Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity , 2005, Nature Genetics.
[18] A. Gottlieb. Psoriasis: emerging therapeutic strategies , 2005, Nature Reviews Drug Discovery.
[19] M. Blaber,et al. Distinct promoters regulate tissue‐specific and differential expression of kallikrein 6 in CNS demyelinating disease , 2004, Journal of neurochemistry.
[20] M. Simon,et al. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. , 2004, The Journal of investigative dermatology.
[21] Moses Rodriguez,et al. Targeting kallikrein 6‐proteolysis attenuates CNS inflammatory disease , 2004, The FASEB Journal.
[22] A. Ishida-Yamamoto,et al. Epidermal lamellar granules transport different cargoes as distinct aggregates. , 2004, The Journal of investigative dermatology.
[23] M. Ghazizadeh,et al. Human airway trypsin-like protease induces PAR-2-mediated IL-8 release in psoriasis vulgaris. , 2004, The Journal of investigative dermatology.
[24] N. Bunnett,et al. Protease-activated receptors: contribution to physiology and disease. , 2004, Physiological reviews.
[25] P. Bellavite,et al. Neutrophil Functions and IL-8 in Psoriatic Arthritis and in Cutaneous Psoriasis , 1998, Inflammation.
[26] G. Yousef,et al. Complex formation between human kallikrein 13 and serum protease inhibitors. , 2004, Clinica chimica acta; international journal of clinical chemistry.
[27] C. Bodemer,et al. LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome. , 2003, Human molecular genetics.
[28] E. Diamandis,et al. Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors. , 2003, Biochemical and biophysical research communications.
[29] K. Mitsudo,et al. Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis. , 2003, Biochemistry.
[30] Toshio Hakoshima,et al. Role of Loop Structures of Neuropsin in the Activity of Serine Protease and Regulated Secretion* , 2002, The Journal of Biological Chemistry.
[31] K. Saijoh,et al. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. , 2002, The Journal of investigative dermatology.
[32] P. Elliott,et al. Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model. , 2002, The Journal of clinical investigation.
[33] G. Yousef,et al. Human Tissue Kallikreins: A New Enzymatic Cascade Pathway? , 2002, Biological chemistry.
[34] M. Simon,et al. Refined Characterization of Corneodesmosin Proteolysis during Terminal Differentiation of Human Epidermis and Its Relationship to Desquamation* , 2001, The Journal of Biological Chemistry.
[35] G. Yousef,et al. The new human tissue kallikrein gene family: structure, function, and association to disease. , 2001, Endocrine reviews.
[36] M. Salis,et al. Local Delivery of Human Tissue Kallikrein Gene Accelerates Spontaneous Angiogenesis in Mouse Model of Hindlimb Ischemia , 2001, Circulation.
[37] K. Wang,et al. Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region. , 2000, Gene.
[38] C. Bodemer,et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome , 2000, Nature Genetics.
[39] M. Brattsand,et al. Stratum corneum tryptic enzyme in normal epidermis: a missing link in the desquamation process? , 2000, The Journal of investigative dermatology.
[40] N. Seidah,et al. Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides 1 Published on the World Wide Web on 17 August 1999. 1 , 1999, Brain Research.
[41] M. Steinhoff,et al. Proteinase‐activated receptor‐2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase , 1999, Experimental dermatology.
[42] M. Reinecke,et al. LEKTI, a Novel 15-Domain Type of Human Serine Proteinase Inhibitor* , 1999, The Journal of Biological Chemistry.
[43] T. Egelrud,et al. Stratum corneum chymotryptic enzyme in psoriasis , 1999, Archives of Dermatological Research.
[44] E. Bröcker,et al. Differential Expression of GRO-α and IL-8 mRNA Psoriasis: A Model for Neutrophil Migration and Accumulation In Vivo , 1996 .
[45] A. Baici,et al. Antileukoprotease Inhibits Stratum Corneum Chymotryptic Enzyme , 1996, The Journal of Biological Chemistry.
[46] H. Tagami,et al. The role of two endogenous proteases of the stratum corneum in degradation of desmoglein‐1 and their reduced activity in the skin of ichthyotic patients , 1996, The British journal of dermatology.
[47] E. Bröcker,et al. Differential expression of GRO-alpha and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo. , 1996, The Journal of investigative dermatology.
[48] J. Van Damme,et al. Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin. , 1989, The American journal of pathology.
[49] D. Steiner. Proteolytic processing. , 1986, Science.